Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The double burden of malnutrition: aetiological pathways and consequences for health

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Myocardial damage after ST-segment elevation myocardial infarction by use of bivalirudin or heparin: a DANAMI-3 substudy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Salivary microbiota and inflammation-related proteins in patients with psoriasis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Alcohol septal ablation in patients with severe septal hypertrophy

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
In low-risk patients, the zotarolimus-eluting stent has been shown to reduce rates of restenosis without increasing the risk of stent thrombosis. We compared the efficacy and safety of the zotarolimus-eluting stent versus the sirolimus-eluting stent in patients with coronary artery disease who were receiving routine clinical care with no direct follow-up.
Original languageEnglish
JournalLancet
Volume375
Issue number9720
Pages (from-to)1090-9
Number of pages10
ISSN0140-6736
DOIs
Publication statusPublished - 27 Mar 2010

ID: 32169133